Deerfield and Stanford University Create the Porter Alliance for Innovative Medicines

Stanford University and Deerfield Management, a healthcare investment firm, have collaborated to create Porter Alliance for Innovative Medicines to accelerate translational research into clinical therapeutics. Deerfield has committed up to $130 million and additional scientific and operational support to this new collaboration to advance research coming out of Stanford faculty laboratories with a focus on drug prototypes emerging from Stanford’s Innovative Medicines Accelerator.